ArticleDrug delivery and translational research2026
Oral nanoparticle-encapsulated enzyme replacement therapy for mucopolysaccharidosis type I (MPS-I): a proof of concept study.
Jose-Victor Álvarez et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it